Guardant Health (GH) Return on Equity (2018 - 2026)

Guardant Health has disclosed Return on Equity across 9 years of filings, most recently posting 0.03% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.03%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03% (up 1.0% YoY), and the FY2025 annual result was 0.03%, up 49.0% from the prior year.
• Return on Equity came in at 0.03% for Q1 2026 at Guardant Health, up from 0.02% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.17% in Q3 2024 to a low of 0.85% in Q1 2023.
• The 5-year median for Return on Equity is 0.01% (2022), against an average of 0.05%.
• Across the five-year window, Return on Equity sank 84 bps in 2023 and soared 81 bps in 2024, its largest moves.
• Guardant Health's Return on Equity stood at 0.06% in 2022, then surged by 57 bps to 0.02% in 2023, then jumped by 276 bps to 0.04% in 2024, then plunged by 58 bps to 0.02% in 2025, then surged by 68 bps to 0.03% in 2026.
• The last three Return on Equity figures came in at 0.03% (Q1 2026), 0.02% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.